CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 4637-4645

  Nakashima, Hiroko ^a,b   Hamaguchi, Yasuhito ^d   Watanabe, Rei ^a   Ishiura, Nobuko ^a   Kuwano, Yoshihiro ^a   Okochi, Hitoshi ^b   Takahashi, Yoshimasa ^c   Tamaki, Kunihiko ^a   Sato, Shinichi ^a   Tedder, Thomas F ^e   Fujimoto, Manabu ^a,b,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CD22 ANTIGEN; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 10 RECEPTOR; SIALIC ACID; CD22 PROTEIN, MOUSE; INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CELL SURVIVAL; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HYPERSENSITIVITY REACTION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; LYMPHOID ORGAN; MOUSE; NONHUMAN; PERITONEAL B 1A CELL; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE; ADOPTIVE TRANSFER; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL MOTION; CONTACT DERMATITIS; CONTACT INHIBITION; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PERITONEUM; PHYSIOLOGY; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD22; B-LYMPHOCYTE SUBSETS; CELL MOVEMENT; CELLS, CULTURED; CONTACT INHIBITION; DERMATITIS, CONTACT; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PERITONEUM;

EID: 77954465634     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901719     Document Type: Article

References (51)

1. Fillatreau, S., D. Gray, and S. M. Anderton. 2008. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 8: 391-397.
2. Bouaziz, J. D., K. Yanaba, and T. F. Tedder. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224: 201-214.
3. Mauri, C., and M. R. Ehrenstein. 2008. The 'short' history of regulatory B cells. Trends Immunol. 29: 34-40.
4. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J. Immunol. 176: 705-710.
5. Wolf, S. D., B. N. Dittel, F. Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
6. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
7. Mizoguchi, A., E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan. 1997. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med. 186: 1749-1756.
8. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230. (Pubitemid 34211962)
9. Evans, J. G., K. A. Chavez-Rueda, A. Eddaoudi, A. Meyer-Bahlburg, D. J. Rawlings, M. R. Ehrenstein, and C. Mauri. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178: 7868-7878.
10. Gray, M., K. Miles, D. Salter, D. Gray, and J. Savill. 2007. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl. Acad. Sci. USA 104: 14080-14085.
11. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
12. Watanabe, R., M. Fujimoto, N. Ishiura, Y. Kuwano, H. Nakashima, N. Yazawa, H. Okochi, S. Sato, T. F. Tedder, and K. Tamaki. 2007. CD19 expression in B cells is important for suppression of contact hypersensitivity. Am. J. Pathol. 171: 560-570.
13. + phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
14. + type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J. Immunol. 165: 6783-6790.
15. Kripke, M. L., C. G. Munn, A. Jeevan, J. M. Tang, and C. Bucana. 1990. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145: 2833-2838.
16. Marchal, G., M. Seman, G. Milon, P. Truffa-Bachi, and V. Zilberfarb. 1982. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J. Immunol. 129: 954-958. (Pubitemid 12055552)
17. + T cell-mediated delayed hypersensitivity: implications for allergies, asthma, and autoimmunity. J. Allergy Clin. Immunol. 103: 192-199.
18. Szczepanik, M., M. Akahira-Azuma, K. Bryniarski, R. F. Tsuji, I. Kawikova, W. Ptak, C. Kiener, R. A. Campos, and P. W. Askenase. 2003. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J. Immunol. 171: 6225-6235. (Pubitemid 37474174)
19. Enk, A. H. 1997. Allergic contact dermatitis: understanding the immune response and potential for targeted therapy using cytokines. Mol. Med. Today 3: 423-428.
20. + T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 168: 3079-3087.
21. Martín, A., N. Gallino, J. Gagliardi, S. Ortiz, A. R. Lascano, A. Diller, M. C. Daraio, A. Kahn, A. L. Mariani, and H. M. Serra. 2002. Early inflammatory markers in elicitation of allergic contact dermatitis. BMC Dermatol. 2: 9. (Pubitemid 38750952)
22. Katz, S. I., D. Parker, and J. L. Turk. 1974. B-cell suppression of delayed hypersensitivity reactions. Nature 251: 550-551.
23. O'Garra, A., R. Chang, N. Go, R. Hastings, G. Haughton, and M. Howard. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
24. Tsubata, T. 1999. Co-receptors on B lymphocytes. Curr. Opin. Immunol. 11: 249-255.
25. Sgroi, D., A. Varki, S. Braesch-Andersen, and I. Stamenkovic. 1993. CD22, a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J. Biol. Chem. 268: 7011-7018.
26. Fujimoto, M., Y. Kuwano, R. Watanabe, N. Asashima, H. Nakashima, S. Yoshitake, H. Okochi, K. Tamaki, J. C. Poe, T. F. Tedder, and S. Sato. 2006. B cell antigen receptor and CD40 differentially regulate CD22 tyrosine phosphorylation. J. Immunol. 176: 873-879. (Pubitemid 43099684)
27. Leprince, C., K. E. Draves, R. L. Geahlen, J. A. Ledbetter, and E. A. Clark. 1993. CD22 associates with the human surface IgM-B-cell antigen receptor complex. Proc. Natl. Acad. Sci. USA 90: 3236-3240.
28. Cyster, J. G., and C. C. Goodnow. 1997. Tuning antigen receptor signaling by CD22: integrating cues from antigens and the microenvironment. Immunity 6: 509-517.
29. Nitschke, L., R. Carsetti, B. Ocker, G. Köhler, and M. C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7: 133-143.
30. O'Keefe, T. L., G. T. Williams, S. L. Davies, and M. S. Neuberger. 1996. Hyperresponsive B cells in CD22-deficient mice. Science 274: 798-801.
31. Otipoby, K. L., K. B. Andersson, K. E. Draves, S. J. Klaus, A. G. Farr, J. D. Kerner, R. M. Perlmutter, C. L. Law, and E. A. Clark. 1996. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature 384: 634-637. (Pubitemid 27021515)
32. Sato, S., A. S. Miller, M. Inaoki, C. B. Bock, P. J. Jansen, M. L. Tang, and T. F. Tedder. 1996. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. Immunity 5: 551-562. (Pubitemid 27062065)
33. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of selfreactive B lymphocytes in transgenic mice. Nature 334: 676-682.
34. Poe, J. C., K. M. Haas, J. Uchida, Y. Lee, M. Fujimoto, and T. F. Tedder. 2004. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background. J. Immunol. 172: 2100-2110.
35. Poe, J. C., Y. Fujimoto, M. Hasegawa, K. M. Haas, A. S. Miller, I. G. Sanford, C. B. Bock, M. Fujimoto, and T. F. Tedder. 2004. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat. Immunol. 5: 1078-1087.
36. Cavani, A., F. Nasorri, C. Prezzi, S. Sebastiani, C. Albanesi, and G. Girolomoni. 2000. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J. Invest. Dermatol. 114: 295-302.
37. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
38. Won, W. J., and J. F. Kearney. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168: 5605-5611.
39. Wortis, H. H., and R. Berland. 2001. Cutting edge commentary: origins of B-1 cells. J. Immunol. 166: 2163-2166.
40. Duan, B., and L. Morel. 2006. Role of B-1a cells in autoimmunity. Autoimmun. Rev. 5: 403-408.
41. Tsuji, R. F., M. Szczepanik, I. Kawikova, V. Paliwal, R. A. Campos, A. Itakura, M. Akahira-Azuma, N. Baumgarth, L. A. Herzenberg, and P.W. Askenase. 2002. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196: 1277-1290.
42. Kawakami, Y., N. Inagaki, S. Salek-Ardakani, J. Kitaura, H. Tanaka, K. Nagao, Y. Kawakami, W. Xiao, H. Nagai, M. Croft, and T. Kawakami. 2006. Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. Proc. Natl. Acad. Sci. USA 103: 153-158.
43. -/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system. J. Immunol. 168: 3105-3112.
44. Peterson, L. K., I. Tsunoda, and R. S. Fujinami. 2008. Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity 41: 353-362. (Pubitemid 351891196)
45. Shimomura, Y., E. Mizoguchi, K. Sugimoto, R. Kibe, Y. Benno, A. Mizoguchi, and A. K. Bhan. 2008. Regulatory role of B-1 B cells in chronic colitis. Int. Immunol. 20: 729-737.
46. Itakura, A., M. Szczepanik, R. A. Campos, V. Paliwal, M. Majewska, H. Matsuda, K. Takatsu, and P. W. Askenase. 2005. An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity. J. Immunol. 175: 7170-7178. (Pubitemid 41713410)
47. Law, C. L., A. Aruffo, K. A. Chandran, R. T. Doty, and E. A. Clark. 1995. Ig domains 1 and 2 of murine CD22 constitute the ligand-binding domain and bind multiple sialylated ligands expressed on B and T cells. J. Immunol. 155: 3368-3376.
48. Peaker, C. J., and M. S. Neuberger. 1993. Association of CD22 with the B cell antigen receptor. Eur. J. Immunol. 23: 1358-1363.
49. Razi, N., and A. Varki. 1999. Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation. Glycobiology 9: 1225-1234.
50. Nitschke, L., H. Floyd, D. J. Ferguson, and P. R. Crocker. 1999. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J. Exp. Med. 189: 1513-1518.
51. Engel, P., L. J. Zhou, D. C. Ord, S. Sato, B. Koller, and T. F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3: 39-50.